Chimeric antigen receptor (CAR)-engineered T cells (CAR-T cells) eliminate tumor cells by directly recognizing extracellular tumor-associated antigens, independently of major histocompatibility complex (MHC)-restricted antigen presentation [1,2]. This evidence concerns the gene HLA-C and neoplasm.